Close Menu

NEW YORK (GenomeWeb) – Swiss startup Scailyte announced yesterday that it has raised CHF 2.8 million (US $2.8 million) in a seed funding round.

The Luzern, Switzerland-based firm will use the capital to improve market entry and to expedite development of ScaiVision, an artificial intelligence-based software that analyzes single-cell data to enhance biomedical research, pharmaceutical discovery, and precision diagnostics.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The US National Institutes of Health's All of Us project awarded $4.6 million to the company Color to develop a genetic counseling resource for the program.

New guidelines say that more women may benefit from genetic testing for hereditary breast or ovarian cancer, according to the Los Angeles Times.

The Times of India reports on a pilot study that used genomic testing to determine whether patients had drug-resistant tuberculosis.

In Cell this week: small proteins identified among human microbiome, role for tumor microbes in pancreatic cancer survival, and more.